Collegium Pharmaceutical Financials

Values in thousands	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Revenue	$181,949	$159,301	$145,276	$144,923
Gross Profit	98,288	96,794	90,806	91,456
EBITDA	38,111	75,721	80,151	89,395
EBIT		33,974	44,684	53,961
Net Income	12,536	9,335	19,606	27,713
Net Change In Cash	181,949	159,301	145,276	144,923
Free Cash Flow	84,074	-9,243	67,128	61,369
Cash	70,565	38,960	172,894	228,610
Basic Shares	40,109	40,163	40,383	41,438

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$631,449	$566,767	$463,933	$276,868
Gross Profit	377,344	326,169	209,488	150,617
EBITDA	169,895	308,328	168,757	86,575
EBIT		159,072	34,366	17,640
Net Income	69,190	48,155	-25,002	71,517
Net Change In Cash	631,449	566,767	463,933	276,868
Cost of Revenue			-12,738	12,310
Free Cash Flow	203,328	274,288	122,608	101,613
Cash	70,565	238,947	173,688	186,426
Basic Shares	40,424	41,788	33,829	41,045